期刊文献+

AA/HPA/AMPS对草酸钙晶相组成及晶粒形貌影响的研究

Modulation of PESA on Ca Ox Crystal Phase Composition and Morphology of Calcium Oxalate
下载PDF
导出
摘要 采用环境扫描电镜(SEM)和X射线衍射(XRD)技术,研究AA/HPA/AMPS在水体系中对草酸钙晶化习性的影响。结果表明:随着添加剂浓度的增加,一水草酸钙(COM)的生长受到抑制,晶粒的聚集度和尺寸降低,棱角变得圆钝,相反,二水草酸钙(COD)和三水草酸钙(COT)的成核得到促进。当添加剂浓度较高时,COD为唯一的晶相。控制单一变量,发现高的过饱和度降低了AA/HPA/AMPS对草酸钙亚稳态晶相的稳定能力,而高p H则增强了AA/HPA/AMPS的调控作用。由分子动力学(MD)模拟可知,AA/HPA/AMPS在草酸钙晶粒的富Ca2+晶面吸附力较强。 The influence of AA/HPA/AMPS on calcium oxalate (CaOx) crystallization has been investigated by SEM and XRD. With increasing the concentration of AA/HPA/AMPS, the growth of CaOx monohydrate crystal (COM) was inhibited. The aggregation level and size of crystal particles were decreased with the edges and comers becoming blunt. On the contrary, the nucleation of CaOx dihydrate (COD) and CaOx trihydrate (COT) was promoted. At higher concentration, COD was precipitated as sole crystal phase. The results at different reaction conditions indicated that the regulation effect of AA/HPA/AMPS on CaOx crystallization could weaken by high supersaturation, but strengthened by high pH. Molecular Dynamics (MD) Simulations showed us that AA/HPA/AMPS was adsorbed on the crystal plane with high Ca2+ preferentially.
出处 《广东化工》 CAS 2015年第9期47-48,41,共3页 Guangdong Chemical Industry
关键词 草酸钙 AA/HPA/AMPS 动力学模拟 calcium oxalate AA/HPA/AMPS Molecular Dynamics (MD) Simulations
  • 引文网络
  • 相关文献

参考文献16

  • 1Yu H, Sheikholeslami R, Doherty W O S. The Deposition of Calcium Oxalate and Amorphous Silica Scale under Dynamic Conditions which Simulate Sugar Mill Evaporators. Dee Chem Fag Mineral Process, 2004, 12(3/4): 309-322.
  • 2Gernot Schubert. Stone analysis. Urol Res, 2006, 34: 146-150.
  • 3Mandel N: Crystal-membrane interaction in kidney stone disease. J Am So Nephrol, 1994: 5.. S37-S45.
  • 4Jeffrey A Wesson, Elaine M Worcester, John H Wiesaner, et al. Mandel and Jack C. Kleinman. Control of calcium oxalate crystal structure and cell adherence by urinery mscromolecules, Kidney International, 1998, 53: 952-957.
  • 5Ouyang J M, Deng S P, Zhong J P, et al. Crystallization of calcium oxalate monohydrate at dipalmitoylphosphatidylcholine monolayers in the presence of chondroitin sulfate A J. Cryst Growth, 2004, 270: 646-654.
  • 6Lijun Wang, Wei Zhang, Roger Qiu S, et al. Inhibition of calcium oxalate monohydrate crystallization by the combination of citrate and osteopontin. Joumal ofCrystalGrowth, 2006, 291: 160-165.
  • 7TaesongJong, Woo-Sik Kim, ChangKyon Choi. Crystal structure and morphology control of calcium oxalate usingbiopolymeric additives in crystallization. Joumal ofCrystalGrowth, 2005, 279: 154-162.
  • 8Jiaguo Yu, Hua Tang, Bei Cheng, et ai. Morphological control of calcium oxalate particles in thepresence of poly-(styrene-alt-maleic acid). Journal of Solid State Chemistry, 2004, 177: 3368-3374.
  • 9Jiaguo Yu, Hua Tang, Bei Cheng. Influence of PSSS additive and temperature on morphology and phase structures of calcium oxalate. Journal of Colloid and Interface Science, 2005, 288: 407-411.
  • 10KLrboa S, Oner M. The role of vinyl sulfonic acid homopotymer in calcium oxalate crystallization. Colloids and Surfaces B: Biointerfaces, 2010, 78(2): 357-362.

相关主题

;
使用帮助 返回顶部